FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally. Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection to become the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term. Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Bionamic specializes in providing innovative solutions for the analysis of life science data, specifically targeting challenges in biopharma research and development. The company has developed a comprehensive data management platform that acts as a single source for all antibody-related discovery and development data. This platform is designed to streamline the process of navigating and interpreting complex datasets, thereby reducing or eliminating manual steps between raw data and actionable results. By enhancing researchers' ability to understand their data, Bionamic aims to facilitate more informed decision-making in the life sciences sector.
IntuiCell
Venture Round in 2021
IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
SAGA Diagnostics
Series A in 2019
SAGA Diagnostics AB is a company specializing in molecular genetic tests and services aimed at enhancing cancer diagnostics and disease monitoring for healthcare providers, biopharmaceutical firms, and academic institutions. Founded in 2016 as a spin-out from a research group at Lund University, SAGA focuses on the analysis of circulating tumor DNA (ctDNA), a critical biomarker for cancer. The company offers a range of services, including gene mutation analysis, chromosome analysis, and non-invasive liquid biopsy testing, which allows for the ultrasensitive detection of actionable mutations. SAGA's proprietary technology supports oncologists and drug developers by enabling the stratification of patient groups and monitoring treatment responses, thereby facilitating more precise cancer medicine and improving patient outcomes. Based in Lund, Sweden, SAGA is driven by a team of experienced scientists and professionals dedicated to advancing cancer research and clinical diagnostics.
Aligned Bio
Aligned Bio is a developer of advanced nanowire-based biosensor platforms that cater to various industries, including biomedicine, water purification, public safety, and personal electronics. The company specializes in creating sensors that are fast, accurate, and highly sensitive, which are essential for a range of applications such as disease diagnosis, pathogen and pesticide identification, and pollution monitoring. Aligned Bio enhances the sensitivity of its biosensors through patented methods for nanowire production and alignment. By providing sensor manufacturers with large-area nanowires and improved signal capacity at a low cost, Aligned Bio aims to advance sensor-based technologies across multiple sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.